Colombo: Facing criticism over the death of a school girl allegedly after being administered with Rubella vaccine, Sri Lanka has said the drug imported from India was of international standard and its quality is good.

Health Minister Nimal Siripala De Silva said the rubella vaccine, an anti-measles drug, being administered in Sri Lanka is purchased from Pune-based Serum Institute of India.

"There is no problem about the quality. The dates for the use of the vaccine had not expired when it was administered," he told Parliament yesterday reacting to reports that a school girl in Wariyapola in northern Sri Lanka died after being administered the vaccine.

In March, a school girl had died under similar circumstances in Matara in southern coast of Sri Lanka forcing the Serum Institute to get the product tested from the Maharashta Government.

"The test proved that there was nothing wrong in the rubella vaccine and it was not sub-standard," the state run Daily News quoted Dr Firdos Rustom Mehta, World Health Organisation Representative to Sri Lanka, as saying.